PRA has created a legal entity in Bulgaria to support growth and expansion of operations in the region. The new entity, located in Sofia, enhances the company's local presence and provides for growth of clinical services in Bulgaria and neighboring countries.
"In addition to our presence in the Central and Eastern European region, PRA's new entity in Bulgaria is a part of our strategic growth and development that clearly demonstrates our commitment to expansion," said Dr. Ludger Langer, PRA's vice president of clinical operations in Europe, Asia-Pacific and Africa. "With over 40 offices worldwide, PRA continues to grow and expand into new regions for clinical research. The legal entity in Bulgaria further demonstrates our commitment to meeting the expanding needs of our clients in an ever-changing clinical trials environment and provides our local teams with a local corporate basis for operations.”